Clinical trial
A Multicenter Prospective Phase II Study of Postoperative Hypofractionated Stereotactic Body Radiotherapy (SBRT) in the Treatment of Early Stage Oropharyngeal and Oral Cavity Cancers With High Risk Margins.
NCT03401840 is registered in ClinicalTrials.gov with Centre Jean Perrin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Prospective Phase II Study of Postoperative Hypofractionated Stereotactic Body Radiotherapy (SBRT) in the Treatment of Early Stage Oropharyngeal and Oral Cavity Cancers With High Risk Margins.
- Lead sponsor
- Centre Jean Perrin
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 23, 2018
- Completion date
- September 28, 2023
- Enrollment
- 90 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.